# Lightpoint Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lightpoint-medical

- Industry: Medical Devices & Equipment
- Headquarters: Chesham, UK
- Website: www.lightpointmedical.com
- Total disclosed funding: $11M
- Latest round: Series C (Mar 25, 2021)
- Investors on record: 10

## About

Lightpoint Medical, Ltd focuses on developing advanced surgical technologies that improve cancer treatment precision, particularly through their innovative SENSEI® probe designed for intraoperative cancer detection.Founded in 2012 in Chesham, UK, Lightpoint Medical, Ltd specializes in advanced surgical technologies aimed at enhancing cancer detection during surgery. The company has undergone strategic growth, having engaged in 11 deals to date, with a recent funding round of GBP 5.840 mn raised in Series C on June 21, 2023, backed by investors such as British Business Bank and Oxford Technology Management. The founder's prior entrepreneurial history is not publicly documented.Lightpoint Medical specializes in advanced technologies aimed at enhancing surgical precision in cancer treatment. The company's flagship product, the SENSEI® probe, is a miniature robotic-assisted gamma probe designed to detect radiation and guide surgeons during operations, particularly in bladder and prostate cancer surgeries. This innovative device utilizes next-generation miniaturized sensors combined with cancer-targeted imaging agents, such as PSMA, to enable real-time detection of cancerous tissues, thereby improving patient outcomes. The SENSEI® probe has been successfully employed in leading international cancer centers across Spain, California, and London, with its products primarily deployed in Europe and North America to meet the increasing demand for intraoperative cancer detection.Lightpoint Medical's revenue model is centered on partnerships and direct sales to healthcare institutions conducting cancer surgeries. The company engages in B2B transactions, providing its SENSEI® probe as an essential tool for minimally invasive procedures. The financial structure involves upfront costs for the probes and potential revenue-sharing agreements, facilitating the adoption of advanced surgical technology in cancer treatment.In June 2023, Lightpoint Medical, Ltd was acquired by Telix Pharmaceuticals Limited, a move aimed at enhancing Telix's innovation and product depth in urology. The acquisition is expected to bolster Lightpoint's strategic direction and product development initiatives moving forward.

## Funding rounds

- Series C, Mar 25, 2021, $8.1M — Oxford Technology Management, Coutts & Co., British Business Bank, VentureFounders
- Series A, Dec 30, 2014, $3.1M — Ruffena Capital, Oxford Technology Management, Cambridge Capital Group, London Business Angels, Envestors, SyndicateRoom
- Seed, Jun 25, 2013, $0.3M — Oxford Technology Management, Oxford Investment Opportunity Network

## Investors

- Oxford Technology Management (https://capitalatlas.ai/funds/oxford-technology-management) — Seed, Series A, Series C
- Oxford Investment Opportunity Network — Seed
- Ruffena Capital (https://capitalatlas.ai/funds/ruffena-capital) — Series A
- Cambridge Capital Group — Series A
- London Business Angels — Series A
- Envestors (https://capitalatlas.ai/funds/envestors) — Series A
- SyndicateRoom (https://capitalatlas.ai/funds/syndicateroom) — Series A
- Coutts & Co. — Series C
- British Business Bank (https://capitalatlas.ai/funds/british-business-bank) — Series C
- VentureFounders — Series C